Genetic Engineering Market Research Report Information By Product (Biochemical and Genetic Markers), By Devices (PCR, Gene Gun, and Gel Assemblies), By Techniques (Artificial Selection and Gene Splicing), By Application (Agriculture and Medical Industry), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Genetic Engineering Market, by Devices

6.1 Introduction

6.2 PCR

6.2.1 Real-Time PCR

6.2.2 Reverse Transcription PCR

6.2.3 Quantitative PCR

6.2.4 Others

6.3 Gene Gun

6.4 Gel Assemblies

6.5 Others

Chapter 7 Global Genetic Engineering Market, by Application

7.1 Introduction

7.2 Agriculture

7.2.1 Bt- Cotton

7.2.2 Golden Rice

7.2.3 Others

7.3 Medical Industry

7.3.1 Recombinant Proteins

7.3.2 Recombinant Antibodies

7.3.3 Others

7.4 Forensic Science

7.5 Others

Chapter 8 Global Genetic Engineering Market, by Techniques

8.1 Introduction

8.2 Artificial Selection

8.3 Cloning

8.4 Gene Splicing

8.5 Others

Chapter 9 Global Genetic Engineering Market, by End-User

9.1 Introduction

9.2 Research Institutes

9.3 Academic Institutes

9.4 Pharmaceutical Industries

9.5 Others

Chapter 10. Global Genetic Engineering Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Merck KGaA

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Horizon Discovery Group Plc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Transposagen Biopharmaceuticals Inc.

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 New England Biolabs.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Genscript Biotech Corporation

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Lonza Group Ltd.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Origene Technologies, Inc

12.8.1 Overview

12.8.2 Product/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Integrated DNA Technologies, Inc.

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Amgen Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Genentech, Inc.

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Sangamo Therapeutics, Inc.

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

Chapter 14 Appendix

LIST OF TABLES

Table 1 Global Genetic Engineering Market Synopsis, 2023–2032

Table 2 Global Genetic Engineering Market Estimates and Forecast, 2023–2032, (USD Million)

Table 3 Global Genetic Engineering Market, by Region, 2023–2032, (USD Million)

Table 4 Global Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 5 Global Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 6 Global Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 7 Global Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 8 Global Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 9 North America Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 10 North America Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 11 North America Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 12 North America Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 13 North America Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 14 US Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 15 US Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 16 US Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 17 US Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 18 US Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 19 Canada Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 20 Canada Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 21 Canada Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 22 Canada Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 23 Canada Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 24 South America Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 25 South America Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 26 South America Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 27 South America Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 28 South America Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 29 Europe Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 30 Europe Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 31 Europe Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 32 Europe Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 33 Europe Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 34 Western Europe Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 35 Western Europe Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 36 Western Europe Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 37 Western Europe Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 38 Western Europe Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 39 Eastern Europe Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 40 Eastern Europe Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 41 Eastern Europe Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 42 Eastern Europe Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 43 Eastern Europe Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 44 Asia-Pacific Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 45 Asia-Pacific Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 46 Asia-Pacific Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 47 Asia-Pacific Genetic Engineering Market, by Techniques, 2023–2032, (USD Million)

Table 49 Asia-Pacific Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

Table 50 Middle East & Africa Genetic Engineering Market, by Product, 2023–2032, (USD Million)

Table 51 Middle East & Africa Genetic Engineering Market, by Devices, 2023–2032, (USD Million)

Table 52 Middle East & Africa Genetic Engineering Market, by Application, 2023–2032, (USD Million)

Table 53 Middle East & Africa Genetic Engineering Market, by Techniques 2023–2032, (USD Million)

Table 54 Middle East & Africa Genetic Engineering Market, by End-User, 2023–2032, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Genetic Engineering Market

Figure 3 Segmentation Market Dynamics for Global Genetic Engineering Market

Figure 4 Global Genetic Engineering Market Share, by Product 2017

Figure 5 Global Genetic Engineering Market Share, by Devices 2017

Figure 6 Global Genetic Engineering Market Share, by Application 2017

Figure 7 Global Genetic Engineering Market Share, by Techniques 2017

Figure 8 Global Genetic Engineering Market Share, by End-User 2017

Figure 9 Global Genetic Engineering Market Share, by Region, 2017

Figure 10 North America Genetic Engineering Market Share, by Country, 2017

Figure 11 Europe Genetic Engineering Market Share, by Country, 2017

Figure 12 Asia-Pacific Genetic Engineering Market Share, by Country, 2017

Figure 13 Middle East & Africa Genetic Engineering Market Share, by Country, 2017

Figure 14 Global Genetic Engineering Market: Company Share Analysis, 2017 (%)

Figure 15 Thermo Fisher Scientific Inc.: Key Financials

Figure 16 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 17 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 18 Merck KGaA: Key Financials

Figure 19 Merck KGaA: Segmental Revenue

Figure 20 Merck KGaA: Geographical Revenue

Figure 21 Genentech, Inc: Key Financials

Figure 22 Genentech, Inc.: Segmental Revenue

Figure 23 Genentech, Inc.: Geographical Revenue

Figure 24 Sangamo Therapeutics, Inc.: Key Financials

Figure 25 Sangamo Therapeutics, Inc.: Segmental Revenue

Figure 26 Sangamo Therapeutics, Inc.: Geographical Revenue

Figure 27 New England Biolabs:Key Financials

Figure 28 New England Biolabs.: Segmental Revenue

Figure 29 New England Biolabs. Geographical Revenue

Figure 30 Genscript Biotech Corporation: Key Financials

Figure 31 Genscript Biotech Corporation: Segmental Revenue

Figure 32 Genscript Biotech Corporation: Geographical Revenue

Figure 33 Origene Technologies, Inc: Key Financials

Figure 34 Origene Technologies, Inc: Segmental Revenue

Figure 35 Origene Technologies, Inc: Geographical Revenue

Figure 36 Sangamo Therapeutics, Inc.: Key Financials

Figure 37 Sangamo Therapeutics, Inc.: Segmental Revenue

Figure 38 Sangamo Therapeutics, Inc.: Geographical Revenue